Bifidobacterium bifidum (B. bifidum) usually represent the most abundant bacteria in the human intestinal flora of healthy breast-fed infants. It shows significant physiological and genetic characteristics, including adhesion to the epithelium and the metabolism of host-derived glycans. Taking advantage of the specific adaptability of B. bifidum to human intestines and its significance in supporting host health, Creative Biolabs launched the drug discovery service for probiotics B. bifidum.

Introduction of B. bifidum

B. bifidum is a bacterial species of the genus Bifidobacterium, family Bifidobacteriaceae, which belongs to the Actinobacteria phylum. It is a Gram-positive microorganism with high G+C DNA content. Like other Bifidobacterium strains, B. bifidum is anaerobic, which means it doesn't need oxygen to survive. It can neither move nor form spores. It is one of the most common probiotics in mammals, including humans. Most of B. bifidum are found in our colon, lower part of the small intestine, breast milk, and vagina.